{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01499",
      "entity_text" : "FXa",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01503",
      "entity_text" : "emicizumab",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_E031" ],
      "TissueType" : [ "tissuelist:TS-0564" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "XREF_BIBR Thus, emicizumab and AT can bind to FIXa, and emicizumab, AT, and TFPI can bind to FXa.",
  "reading_complete" : "2020-08-03T12:56:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:54:35Z",
  "trigger" : "bind",
  "evidence" : [ "emicizumab, AT, and TFPI can bind to FXa" ],
  "pmc_id" : "6524866",
  "score" : 0
}